Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
AstraZeneca
Boehringer Ingelheim
Express Scripts
Johnson and Johnson

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Natural alpha interferon

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Natural alpha interferon: Patents, clinical trial progress, indications

Natural alpha interferon is an investigational drug.

There have been 29 clinical trials for Natural alpha interferon. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2015.

The most common disease conditions in clinical trials are Hepatitis, HIV Infections, and Pulmonary Disease, Chronic Obstructive. The leading clinical trial sponsors are National Cancer Institute (NCI), Amarillo Biosciences, Inc., and National Institute of Allergy and Infectious Diseases (NIAID).

There are two US patents protecting this investigational drug and fifty-seven international patents.

Recent Clinical Trials for Natural alpha interferon
TitleSponsorPhase
Polarized Dendritic Cell (aDC1) Vaccine, Interferon Alpha-2, Rintalolimid, and Celecoxib for the Treatment of HLA-A2+ Refractory MelanomaNational Cancer Institute (NCI)Phase 2
Polarized Dendritic Cell (aDC1) Vaccine, Interferon Alpha-2, Rintalolimid, and Celecoxib for the Treatment of HLA-A2+ Refractory MelanomaRoswell Park Cancer InstitutePhase 2
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before SurgeryNational Cancer Institute (NCI)Phase 2

See all Natural alpha interferon clinical trials

Clinical Trial Summary for Natural alpha interferon

Top disease conditions for Natural alpha interferon
Top clinical trial sponsors for Natural alpha interferon

See all Natural alpha interferon clinical trials

US Patents for Natural alpha interferon

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Natural alpha interferon   Start Trial Alpha interferon composition and method for its production from human peripheral blood leukocytes Interferon Sciences, Inc. (New Brunswick, NJ)   Start Trial
Natural alpha interferon   Start Trial Methods for making proteins containing free cysteine residues Bolder Biotechnology, Inc. (Louisville, CO)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Natural alpha interferon

Drugname Country Document Number Estimated Expiration Related US Patent
Natural alpha interferon Austria 367398 2019-01-14   Start Trial
Natural alpha interferon Austria 375363 2017-07-14   Start Trial
Natural alpha interferon Austria 526401 2017-07-14   Start Trial
Natural alpha interferon Australia 2001274853 2017-07-14   Start Trial
Natural alpha interferon Australia 2002306305 2017-07-14   Start Trial
Natural alpha interferon Australia 2004231217 2017-07-14   Start Trial
Natural alpha interferon Australia 2413300 2017-07-14   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Dow
Boehringer Ingelheim
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.